AstraZeneca PLC Valuation
| A1ZN34 Stock | BRL 67.34 0.19 0.28% |
At this time, the firm appears to be overvalued. AstraZeneca PLC shows a prevailing Real Value of R$57.56 per share. The current price of the firm is R$67.34. Our model approximates the value of AstraZeneca PLC from analyzing the firm fundamentals such as Return On Equity of 0.0863, profit margin of 0.07 %, and Current Valuation of 1.25 T as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that AstraZeneca PLC's price fluctuation is very steady at this time. Calculation of the real value of AstraZeneca PLC is based on 3 months time horizon. Increasing AstraZeneca PLC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since AstraZeneca PLC is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AstraZeneca Stock. However, AstraZeneca PLC's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 67.34 | Real 57.56 | Hype 69.46 | Naive 69.98 |
The real value of AstraZeneca Stock, also known as its intrinsic value, is the underlying worth of AstraZeneca PLC Company, which is reflected in its stock price. It is based on AstraZeneca PLC's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AstraZeneca PLC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of AstraZeneca PLC helps investors to forecast how AstraZeneca stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AstraZeneca PLC more accurately as focusing exclusively on AstraZeneca PLC's fundamentals will not take into account other important factors: AstraZeneca PLC Total Value Analysis
AstraZeneca PLC is presently forecasted to have takeover price of 1.25 T with market capitalization of 1.13 T, debt of 28.13 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the AstraZeneca PLC fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.25 T | 1.13 T | 28.13 B |
AstraZeneca PLC Investor Information
The book value of the company was presently reported as 11.96. The company has Price/Earnings To Growth (PEG) ratio of 0.68. AstraZeneca PLC last dividend was issued on the 11th of August 2022. Based on the measurements of operating efficiency obtained from AstraZeneca PLC's historical financial statements, AstraZeneca PLC is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.AstraZeneca PLC Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. AstraZeneca PLC has an asset utilization ratio of 35.51 percent. This suggests that the Company is making R$0.36 for each dollar of assets. An increasing asset utilization means that AstraZeneca PLC is more efficient with each dollar of assets it utilizes for everyday operations.AstraZeneca PLC Profitability Analysis
The company reported the revenue of 37.42 B. Net Income was 112 M with profit before overhead, payroll, taxes, and interest of 35.73 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AstraZeneca PLC's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AstraZeneca PLC and how it compares across the competition.
About AstraZeneca PLC Valuation
The stock valuation mechanism determines AstraZeneca PLC's current worth on a weekly basis. Our valuation model uses a comparative analysis of AstraZeneca PLC. We calculate exposure to AstraZeneca PLC's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AstraZeneca PLC's related companies.8 Steps to conduct AstraZeneca PLC's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AstraZeneca PLC's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AstraZeneca PLC's valuation analysis, follow these 8 steps:- Gather financial information: Obtain AstraZeneca PLC's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine AstraZeneca PLC's revenue streams: Identify AstraZeneca PLC's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research AstraZeneca PLC's industry and market trends, including the size of the market, growth rate, and competition.
- Establish AstraZeneca PLC's growth potential: Evaluate AstraZeneca PLC's management, business model, and growth potential.
- Determine AstraZeneca PLC's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AstraZeneca PLC's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for AstraZeneca Stock analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |